Literature DB >> 6956514

Development and cross-resistance characteristics of a subline of P388 leukemia resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide.

R K Johnson, W S Howard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6956514     DOI： 10.1016/0277-5379(82)90117-1

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN： 0277-5379


× No keyword cloud information.
  5 in total

Review 1.  Topoisomerase II in multiple drug resistance.

Authors:  G A Hofmann; M R Mattern
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

2.  Doxorubicin sensitivity pattern in a panel of small-cell lung-cancer cell lines: correlation to etoposide and vincristine sensitivity and inverse correlation to carmustine sensitivity.

Authors:  P B Jensen; H Roed; M Sehested; E J Demant; L Vindeløv; I J Christensen; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  Cross-resistance of drug-resistant murine P388 leukemias to taxol in vivo.

Authors:  W R Waud; K S Gilbert; S D Harrison; D P Griswold
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  In vitro evaluation of the potential of aclarubicin in the treatment of small cell carcinoma of the lung (SCCL).

Authors:  P B Jensen; L Vindeløv; H Roed; E J Demant; M Sehested; T Skovsgaard; H H Hansen
Journal:  Br J Cancer       Date:  1989-12       Impact factor: 7.640

5.  Characterization of an etoposide-resistant human K562 cell line, K/eto.

Authors:  I Sugawara; T Iwahashi; K Okamoto; Y Sugimoto; H Ekimoto; T Tsuruo; T Ikeuchi; S Mori
Journal:  Jpn J Cancer Res       Date:  1991-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.